Acquisition of Lund Research Center (SE) by Active Biotech AB (SE) from Pharmacia & Upjohn (US) — SEK 380 million Healthcare Acquisition of Lund Research Center (SE) by Active Biotech AB (SE) from Pharmacia & Upjohn (US) — SEK 380 million
Initial public offering of CRI-Gruppen ASA (NO) — NOK 100 million TMT Initial public offering of CRI-Gruppen ASA (NO) — NOK 100 million
Acquisition of CarPark (SE) by UBS Capital B.V. (NL) — Amount not disclosed. Real Estate Acquisition of CarPark (SE) by UBS Capital B.V. (NL) — Amount not disclosed.
Rights issue in Active Biotech (SE) — SEK 255 million Healthcare Rights issue in Active Biotech (SE) — SEK 255 million
Secondary offering in Intentia (SE) — SEK 550 million TMT Secondary offering in Intentia (SE) — SEK 550 million
Initial public offering of Prevas (SE) — SEK 94 million TMT Initial public offering of Prevas (SE) — SEK 94 million
New share issue in Agresso ASA (NO) — NOK 120 million TMT New share issue in Agresso ASA (NO) — NOK 120 million
Initial public offering of Sponda (FI) — FIM 840 million Real Estate Initial public offering of Sponda (FI) — FIM 840 million
New share issue in Intentia (SE) — SEK 520 million TMT New share issue in Intentia (SE) — SEK 520 million
Divestment of NTR (SE) by Ratos (SE) to Swedcarrier (SE) — Amount not disclosed. Transportation & Shipping Divestment of NTR (SE) by Ratos (SE) to Swedcarrier (SE) — Amount not disclosed.
Acquisition of ElTele Øst AS (NO) by France Telecom (FR) — NOK 145 million TMT Acquisition of ElTele Øst AS (NO) by France Telecom (FR) — NOK 145 million
Redemption offering in ASG (SE) — SEK 1.2 billion Transportation & Shipping Redemption offering in ASG (SE) — SEK 1.2 billion